Gamma-aminobutyric acid receptor subunit alpha-5
Homo sapiens
当前结构中的状态
| Assembly | 聚集状态 | 构建体 | 突变与修饰 | 配体、离子与共同组分 | 实验方法与环境 | 结构质量 |
|---|---|---|---|---|---|---|
| 1 | 蛋白同源多聚体 同源多聚体 蛋白 × 5 PDB 声明:pentameric(5) 与蛋白拷贝数一致 | 链 A; UniProt 32–315 链 A; UniProt 424–450 链 B; UniProt 32–315 链 B; UniProt 424–450 链 C; UniProt 32–315 链 C; UniProt 424–450 链 D; UniProt 32–315 链 D; UniProt 424–450 链 E; UniProt 32–315 链 E; UniProt 424–450 | 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 QR3 2-[[5-methyl-3-(6-methylpyridazin-3-yl)-1,2-oxazol-4-yl]methyl]-5-(5-oxa-2-azaspiro[3.5]nonan-2-yl)pyridazin-3-one × 5 | ELECTRON MICROSCOPY cryo-EM缓冲液:pH 7.4 cryo-EM玻璃化条件:冷冻剂 ETHANE | 分辨率 3.30 Å |
数据库中的同蛋白其他状态
以下每一行都是同一 UniProt 蛋白在另一个 PDB 条目中的 biological assembly, “相对当前条目”直接指出证据层面的不同;没有差异标签表示当前已读取字段一致。
| 其他 PDB | 相对当前条目 8BHQ | Assembly / 聚集状态 | 构建体 | 突变与修饰 | 配体、离子与非聚合物 | 实验方法与环境 | 结构质量 |
|---|---|---|---|---|---|---|---|
| 5O8F Structure of a chimaeric beta3-alpha5 GABAA receptor in complex with nanobody Nb25 and pregnanolone 提交 2017-06-13 | 构建体不同 突变/修饰不同 聚集状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量不同 | Assembly 1 信息不足 异源复合物;蛋白 × 10 PDB 声明:decameric |
链 A
261–346(86 aa)
链 A
424–462(39 aa)
链 B
261–346(86 aa)
链 B
424–462(39 aa)
链 C
261–346(86 aa)
链 C
424–462(39 aa)
链 D
261–346(86 aa)
链 D
424–462(39 aa)
链 E
261–346(86 aa)
链 E
424–462(39 aa)
|
未记录 | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 P9N Pregnanolone × 5 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 5.6;277 K;14% PEG 6000, 0.1M N-(2-Acetamido)iminodiacetic acid (ADA), 7.6 mM 4-Cyclohexyl-1-Butyl-beta-D-Maltoside (CYMAL-4)
|
分辨率 3.20 Å R-free 0.242 |
| 5OJM Structure of a chimaeric beta3-alpha5 GABAA receptor in complex with nanobody Nb25 提交 2017-07-21 | 构建体不同 突变/修饰不同 聚集状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量不同 | Assembly 1 信息不足 异源复合物;蛋白 × 10 PDB 声明:decameric |
链 A
257–346(90 aa)
链 A
424–462(39 aa)
链 B
257–346(90 aa)
链 B
424–462(39 aa)
链 C
257–346(90 aa)
链 C
424–462(39 aa)
链 D
257–346(90 aa)
链 D
424–462(39 aa)
链 E
257–346(90 aa)
链 E
424–462(39 aa)
|
未记录 | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 5.8;277.15 K;14% poly-ethylene glycol (PEG) 5000, 0.08M magnesium acetate, 0.1M sodium citrate, 1mM ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA)
|
分辨率 3.30 Å R-free 0.250 |
| 6A96 Cryo-EM structure of the human alpha5beta3 GABAA receptor in complex with GABA and Nb25 提交 2018-07-11 | 构建体不同 突变/修饰不同 聚集状态不同 配体/离子不同 结构质量不同 | Assembly 1 其他组合 异源复合物;蛋白 × 8 PDB 声明:octameric |
链 A
1–346(346 aa)
链 A
424–462(39 aa)
|
未记录 | ABU GAMMA-AMINO-BUTANOIC ACID × 1 |
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.51 Å |
| 8BEJ GABA-A receptor a5 homomer - a5V3 - APO 提交 2022-10-21 | 构建体不同 配体/离子不同 结构质量不同 | Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 5 PDB 声明:pentameric |
链 A
32–345(314 aa)
链 A
424–450(27 aa)
链 B
32–345(314 aa)
链 B
424–450(27 aa)
链 C
32–345(314 aa)
链 C
424–450(27 aa)
链 D
32–345(314 aa)
链 D
424–450(27 aa)
链 E
32–345(314 aa)
链 E
424–450(27 aa)
|
突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 |
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.24 Å |
| 8BGI GABA-A receptor a5 homomer - a5V1 - Flumazenil 提交 2022-10-27 | 构建体不同 突变/修饰不同 配体/离子不同 实验方法不同 实验环境不同 结构质量不同 | Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 5 PDB 声明:pentameric |
链 A
32–346(315 aa)
链 A
424–450(27 aa)
链 B
32–346(315 aa)
链 B
424–450(27 aa)
链 C
32–346(315 aa)
链 C
424–450(27 aa)
链 D
32–346(315 aa)
链 D
424–450(27 aa)
链 E
32–346(315 aa)
链 E
424–450(27 aa)
|
未记录 | SO4 SULFATE ION × 29 FYP ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate × 5 P9N Pregnanolone × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;279 K;19 % PEG 1000
0.1 M sodium chloride
0.15 M ammonium sulfate
0.1 M 2-(N-morpholino)ethanesulfonic acid (MES) pH 6.5
25 mM Sucrose monodecanoate detergent (sucrose monocaprate)
|
分辨率 2.56 Å R-free 0.277 |
| 8BHA GABA-A receptor a5 homomer - a5V3 - Basmisanil - HR 提交 2022-10-30 | 配体/离子不同 结构质量不同 | Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 5 PDB 声明:pentameric |
链 A
32–315(284 aa)
链 A
424–450(27 aa)
链 B
32–315(284 aa)
链 B
424–450(27 aa)
链 C
32–315(284 aa)
链 C
424–450(27 aa)
链 D
32–315(284 aa)
链 D
424–450(27 aa)
链 E
32–315(284 aa)
链 E
424–450(27 aa)
|
突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 QI0 Basmisanil × 5 |
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.67 Å |
| 8BHB GABA-A receptor a5 homomer - a5V3 - RO154513 提交 2022-10-30 | 配体/离子不同 结构质量不同 | Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 5 PDB 声明:pentameric |
链 A
32–315(284 aa)
链 A
424–450(27 aa)
链 B
32–315(284 aa)
链 B
424–450(27 aa)
链 C
32–315(284 aa)
链 C
424–450(27 aa)
链 D
32–315(284 aa)
链 D
424–450(27 aa)
链 E
32–315(284 aa)
链 E
424–450(27 aa)
|
突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 EIE ethyl 8-[(azanylidene-$l^{4}-azanylidene)amino]-5-methyl-6-oxidanylidene-4~{H}-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate × 5 |
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.54 Å |
| 8BHG GABA-A receptor a5 heteromer - a5V2 - Bretazenil 提交 2022-10-31 | 构建体不同 突变/修饰不同 聚集状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量不同 | Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 5 PDB 声明:pentameric |
链 A
32–451(420 aa)
链 C
32–451(420 aa)
链 D
32–451(420 aa)
链 E
32–451(420 aa)
|
突变:;I79M,T82N,V98I,R101A,S103T,N121D,L123R,L124V,S126D,K127Q,G138D,I142F,N145W,L152M,L155I,E156W,D157N,T160R,L161V,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,N121D,L123R,L124V,S126D,K127Q,G138D,I142F,N145W,L152M,L155I,E156W,D157N,T160R,L161V,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,N121D,L123R,L124V,S126D,K127Q,G138D,I142F,N145W,L152M,L155I,E156W,D157N,T160R,L161V,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,N121D,L123R,L124V,S126D,K127Q,G138D,I142F,N145W,L152M,L155I,E156W,D157N,T160R,L161V,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; | QMU Bretazenil × 5 DMU DECYL-BETA-D-MALTOPYRANOSIDE × 5 NO3 NITRATE ION × 3 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;279 K;22% PEG 400
0.37M potassium nitrate
0.1 M 2-(N-morpholino)ethanesulfonic acid (MES) pH 6.5
|
分辨率 2.39 Å R-free 0.283 |
| 8BHI GABA-A receptor a5 homomer - a5V3 - RO5211223 提交 2022-10-31 | 配体/离子不同 结构质量不同 | Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 5 PDB 声明:pentameric |
链 A
32–315(284 aa)
链 A
424–450(27 aa)
链 B
32–315(284 aa)
链 B
424–450(27 aa)
链 C
32–315(284 aa)
链 C
424–450(27 aa)
链 D
32–315(284 aa)
链 D
424–450(27 aa)
链 E
32–315(284 aa)
链 E
424–450(27 aa)
|
突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 QKF [1,1-bis(oxidanylidene)-1,4-thiazinan-4-yl]-[6-[[5-methyl-3-(6-methylpyridin-3-yl)-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone × 5 |
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.67 Å |
| 8BHK GABA-A receptor a5 homomer - a5V3 - Diazepam 提交 2022-10-31 | 配体/离子不同 | Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 5 PDB 声明:pentameric |
链 A
32–315(284 aa)
链 A
424–450(27 aa)
链 B
32–315(284 aa)
链 B
424–450(27 aa)
链 C
32–315(284 aa)
链 C
424–450(27 aa)
链 D
32–315(284 aa)
链 D
424–450(27 aa)
链 E
32–315(284 aa)
链 E
424–450(27 aa)
|
突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 DZP 7-CHLORO-1-METHYL-5-PHENYL-1,3-DIHYDRO-2H-1,4-BENZODIAZEPIN-2-ONE × 5 |
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.30 Å |
| 8BHM GABA-A receptor a5 homomer - a5V3 - DMCM 提交 2022-10-31 | 配体/离子不同 结构质量不同 | Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 5 PDB 声明:pentameric |
链 A
32–315(284 aa)
链 A
424–450(27 aa)
链 B
32–315(284 aa)
链 B
424–450(27 aa)
链 C
32–315(284 aa)
链 C
424–450(27 aa)
链 D
32–315(284 aa)
链 D
424–450(27 aa)
链 E
32–315(284 aa)
链 E
424–450(27 aa)
|
突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 R63 methyl 4-ethyl-6,7-dimethoxy-9H-pyrido[3,4-b]indole-3-carboxylate × 5 |
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.95 Å |
| 8BHO GABA-A receptor a5 homomer - a5V3 - L655708 提交 2022-10-31 | 配体/离子不同 结构质量不同 | Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 5 PDB 声明:pentameric |
链 A
32–315(284 aa)
链 A
424–450(27 aa)
链 B
32–315(284 aa)
链 B
424–450(27 aa)
链 C
32–315(284 aa)
链 C
424–450(27 aa)
链 D
32–315(284 aa)
链 D
424–450(27 aa)
链 E
32–315(284 aa)
链 E
424–450(27 aa)
|
突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 QMJ ethyl (7~{S})-15-methoxy-12-oxidanylidene-2,4,11-triazatetracyclo[11.4.0.0^{2,6}.0^{7,11}]heptadeca-1(17),3,5,13,15-pentaene-5-carboxylate × 5 |
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.93 Å |
| 8BHR GABA-A receptor a5 homomer - a5V3 - RO7015738 提交 2022-10-31 | 配体/离子不同 结构质量不同 | Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 5 PDB 声明:pentameric |
链 A
32–315(284 aa)
链 A
424–450(27 aa)
链 B
32–315(284 aa)
链 B
424–450(27 aa)
链 C
32–315(284 aa)
链 C
424–450(27 aa)
链 D
32–315(284 aa)
链 D
424–450(27 aa)
链 E
32–315(284 aa)
链 E
424–450(27 aa)
|
突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 QM7 6-[[5-methyl-3-(6-methylpyridin-3-yl)-1,2-oxazol-4-yl]methoxy]-~{N}-[(2~{S})-1-oxidanylpentan-2-yl]pyridine-3-carboxamide × 5 |
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.38 Å |
| 8BHS GABA-A receptor a5 homomer - a5V3 - RO4938581 提交 2022-10-31 | 构建体不同 配体/离子不同 结构质量不同 | Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 5 PDB 声明:pentameric |
链 A
32–346(315 aa)
链 A
424–450(27 aa)
链 B
32–346(315 aa)
链 B
424–450(27 aa)
链 C
32–346(315 aa)
链 C
424–450(27 aa)
链 D
32–346(315 aa)
链 D
424–450(27 aa)
链 E
32–346(315 aa)
链 E
424–450(27 aa)
|
突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; 突变:;I79M,T82N,V98I,R101A,S103T,I142F,N145W,K151R,L152M,L155I,E156W,D157N,T160R,L161V,M165L,Q176D,A184E,H185Q,A186N,P287A,I336L,T340F,F344I,V335I ; | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 QK9 5-[bis(fluoranyl)methyl]-15-bromanyl-2,4,8,9,11-pentazatetracyclo[11.4.0.0^{2,6}.0^{8,12}]heptadeca-1(13),3,5,9,11,14,16-heptaene × 5 |
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.24 Å |
| 9HAA a5b3 GABAA Receptor resting state 提交 2024-11-02 | 构建体不同 突变/修饰不同 聚集状态不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 信息不足 异源复合物;蛋白 × 5 PDB 声明:pentameric |
链 A
33–346(314 aa)
链 A
421–462(42 aa)
链 D
33–346(314 aa)
链 D
421–462(42 aa)
|
未记录 | BUA butanoic acid × 2 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1 ZN ZINC ION × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5;20 mM HEPES, 100 mM NaCl, 2 mM Fluorinated Fos-choline 8, 0.005% LMNG, 0.0005% CHS
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.14 Å |
| 9HNQ a5b3 GABAA Receptor bound to GABA and Mb25 in desensitized state in detergent micelles 提交 2024-12-11 | 构建体不同 突变/修饰不同 聚集状态不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric |
链 A
33–346(314 aa)
链 A
421–462(42 aa)
链 D
33–346(314 aa)
链 D
421–462(42 aa)
|
未记录 | ABU GAMMA-AMINO-BUTANOIC ACID × 2 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5;20 mM HEPES, 100 mM NaCl, 0.005% LMNG, 0.0005% CHS
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.81 Å |
| 9HNR a5b3 GABAA Receptor in 1 a5 to 4 b3 stoichiometry in desensitized state 提交 2024-12-11 | 构建体不同 突变/修饰不同 聚集状态不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 信息不足 异源复合物;蛋白 × 8 PDB 声明:octameric |
链 A
33–346(314 aa)
链 A
421–462(42 aa)
|
未记录 | ABU GAMMA-AMINO-BUTANOIC ACID × 1 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2 |
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.17 Å |
| 9HNS a5b3 GABAAR bound to GABA and Mb25 in a desensitized state in saposin nanodiscs after long GABA treatment 提交 2024-12-11 | 构建体不同 突变/修饰不同 聚集状态不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric |
链 A
33–346(314 aa)
链 A
421–462(42 aa)
链 D
33–346(314 aa)
链 D
421–462(42 aa)
|
未记录 | ABU GAMMA-AMINO-BUTANOIC ACID × 2 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.10 Å |
| 9HNT a5b3 GABAAR bound to Etomidate, GABA, and Mb25 in a desensitized state in saposin nanodiscs 提交 2024-12-11 | 构建体不同 突变/修饰不同 聚集状态不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric |
链 A
33–346(314 aa)
链 A
421–462(42 aa)
链 D
33–346(314 aa)
链 D
421–462(42 aa)
|
未记录 | V8D Etomidate × 2 ABU GAMMA-AMINO-BUTANOIC ACID × 2 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.32 Å |
| 9HUM a5b3 GABAAR bound to GABA and Mb25 in a desensitized state in saposin nanodiscs after short GABA treatment 提交 2024-12-23 | 构建体不同 突变/修饰不同 聚集状态不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric |
链 A
33–345(313 aa)
链 A
421–462(42 aa)
链 D
33–345(313 aa)
链 D
421–462(42 aa)
|
未记录 | ABU GAMMA-AMINO-BUTANOIC ACID × 2 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.35 Å |
| 9RL5 a5b3 GABAAR bound to Topiramate, GABA, and Mb25 in a desensitized state in saposin nanodiscs 提交 2025-06-16 | 构建体不同 突变/修饰不同 聚集状态不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric |
链 A
33–346(314 aa)
链 A
421–462(42 aa)
链 D
33–346(314 aa)
链 D
421–462(42 aa)
|
未记录 | ABU GAMMA-AMINO-BUTANOIC ACID × 2 TOR [(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate × 2 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.10 Å |
| 9RPB a5b3 GABAAR bound to GABA, and Mb25 in a desensitized state in saposin nanodiscs, topiramate-free 提交 2025-06-24 | 构建体不同 突变/修饰不同 聚集状态不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric |
链 A
33–346(314 aa)
链 A
421–462(42 aa)
链 D
33–346(314 aa)
链 D
421–462(42 aa)
|
未记录 | ABU GAMMA-AMINO-BUTANOIC ACID × 2 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.10 Å |
共 22 个其他 PDB 条目、22 个 assembly。 打开独立比较页并筛选聚集状态
查看构建体与数据证据
| UniProt名称 | GBRA5_HUMAN |
| Isoform | — |
| PDB实体 | 1 |
| 链与序列区间 | 作者链 A; PDB构建体 1–284; UniProt 32–315 作者链 A; PDB构建体 323–349; UniProt 424–450 作者链 B; PDB构建体 1–284; UniProt 32–315 作者链 B; PDB构建体 323–349; UniProt 424–450 作者链 C; PDB构建体 1–284; UniProt 32–315 作者链 C; PDB构建体 323–349; UniProt 424–450 作者链 D; PDB构建体 1–284; UniProt 32–315 作者链 D; PDB构建体 323–349; UniProt 424–450 作者链 E; PDB构建体 1–284; UniProt 32–315 作者链 E; PDB构建体 323–349; UniProt 424–450 |